GENELUX Corp financial data

Symbol
GNLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2625 Townsgate Road, Suite 230, Westlake Village, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 340 %
Debt-to-equity 46 %
Return On Equity -128 % -383%
Return On Assets -87.4 %
Operating Margin -14.2 K % -52117%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.9 M shares +8.92%
Common Stock, Shares, Outstanding 27 M shares +9.95%
Entity Public Float 671 M USD
Common Stock, Value, Issued 27 K USD +8%
Weighted Average Number of Shares Outstanding, Basic 26.8 M shares +37.2%
Weighted Average Number of Shares Outstanding, Diluted 26.8 M shares +37.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8 K USD -95.3%
Research and Development Expense 13.9 M USD +45.8%
General and Administrative Expense 11.9 M USD +54.6%
Operating Income (Loss) -25.8 M USD -330%
Nonoperating Income (Expense) 35 K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.35 M USD -189%
Net Income (Loss) Attributable to Parent -25.8 M USD -119%
Earnings Per Share, Basic -0.92 USD/shares -35.3%
Earnings Per Share, Diluted -0.92 USD/shares +45.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.06 M USD -60.7%
Cash, Cash Equivalents, and Short-term Investments 19.6 M USD
Assets, Current 21.2 M USD +75.9%
Property, Plant and Equipment, Net 1.12 M USD +80.9%
Operating Lease, Right-of-Use Asset 2.26 M USD +22.3%
Other Assets, Noncurrent 92 K USD 0%
Assets 24.7 M USD +68.8%
Employee-related Liabilities, Current 2.68 M USD
Liabilities, Current 7.81 M USD -26%
Operating Lease, Liability, Noncurrent 1.79 M USD +29.3%
Liabilities 9.59 M USD -19.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5 K USD -350%
Retained Earnings (Accumulated Deficit) -229 M USD -12.7%
Stockholders' Equity Attributable to Parent 15.1 M USD +461%
Liabilities and Equity 24.7 M USD +68.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.35 M USD +5.14%
Net Cash Provided by (Used in) Financing Activities 688 K USD -95.3%
Net Cash Provided by (Used in) Investing Activities -1.69 M USD -1451%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 27 M shares +9.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.36 M USD -154%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.06 M USD -60.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 72 K USD -72.7%
Deferred Tax Assets, Valuation Allowance 58.9 M USD +17.5%
Deferred Tax Assets, Gross 58.9 M USD +17.5%
Operating Lease, Liability 2.37 M USD +21.6%
Depreciation 84 K USD -38.2%
Payments to Acquire Property, Plant, and Equipment 30 K USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.87 M USD +24.1%
Property, Plant and Equipment, Gross 4.65 M USD +25.5%
Operating Lease, Liability, Current 584 K USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year Two 330 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 653 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 362 K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.3 K USD
Deferred Federal Income Tax Expense (Benefit) 4.88 M USD +41.4%
Preferred Stock, Shares Authorized 10 M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 331 K USD
Operating Lease, Payments 148 K USD +29.8%
Additional Paid in Capital 245 M USD +18.5%
Current State and Local Tax Expense (Benefit) -2.55 M USD -2839%
Current Federal Tax Expense (Benefit) -6.01 M USD -2431%
Deferred Tax Assets, Net of Valuation Allowance 62.8 M USD +18.3%
Share-based Payment Arrangement, Expense 1.49 M USD +556%
Deferred State and Local Income Tax Expense (Benefit) 2.23 M USD +314%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares